Items where Author is "Sikalengo, G."

2023

Zwyer, M. and Rutaihwa, L. K. and Windels, E. and Hella, J. and Menardo, F. and Sasamalo, M. and Sommer, G. and Schmülling, L. and Borrell, S. and Reinhard, M. and Dötsch, A. and Hiza, H. and Stritt, C. and Sikalengo, G. and Fenner, L. and De Jong, B. C. and Kato-Maeda, M. and Jugheli, L. and Ernst, J. D. and Niemann, S. and Jeljeli, L. and Ballif, M. and Egger, M. and Rakotosamimanana, N. and Yeboah-Manu, D. and Asare, P. and Malla, B. and Dou, H. Y. and Zetola, N. and Wilkinson, R. J. and Cox, H. and Carter, E. J. and Gnokoro, J. and Yotebieng, M. and Gotuzzo, E. and Abimiku, A. and Avihingsanon, A. and Xu, Z. M. and Fellay, J. and Portevin, D. and Reither, K. and Stadler, T. and Gagneux, S. and Brites, D.. (2023) Back-to-Africa introductions of Mycobacterium tuberculosis as the main cause of tuberculosis in Dar es Salaam, Tanzania. PLoS Pathog, 19 (4). e1010893.

2021

Kümmerle, A. and Sikalengo, G. and Vanobberghen, F. and Ndege, R. C. and Foe, G. and Schlaeppi, C. and Burri, C. and Battegay, M. and Paris, D. H. and Glass, T. R. and Weisser, M. and Marzolini, C. and Kiularco Study Group, . (2021) Recognition and management of clinically significant drug-drug interactions between antiretrovirals and co-medications in a cohort of people living with HIV in rural Tanzania: a prospective questionnaire-based study. J Antimicrob Chemother, 76 (10). pp. 2681-2689.

2019

Schlaeppi, C. and Vanobberghen, F. and Sikalengo, G. and Glass, T. R. and Ndege, R. C. and Foe, G. and Kuemmerle, A. and Paris, D. H. and Battegay, M. and Marzolini, C. and Weisser, M. and Kilombero Ulanga Antiretroviral Cohort study group, . (2019) Prevalence and management of drug-drug interactions with antiretroviral treatment in 2069 people living with HIV in rural Tanzania: a prospective cohort study. HIV Medicine, 21 (1). pp. 53-63.